It’s a great idea to invest in us – and here’s why
- Poised for long-term growth; building on attractive mega trends in Life Science, Healthcare and Electronics
- Resilient and high-quality cashflow profile; reliable cash generation leveraging multi-industry set up
- Strong M&A track record enhanced by rapid deleveraging
- Bringing innovation faster to patients and customers, contributing to their sustainability efforts

Related News
View All News-
Press Releases
Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks ...
Merck KGaA, Darmstadt, Germany, and SpringWorks Therapeutics, have entered into a definitive agreement for us to acquire SpringWorks.
2025/04/28
-
Press Releases
Annual General Meeting Approves All Agenda Items
Our 30th Annual General Meeting approved all resolutions on the agenda, including the proposed dividend of € 2.20 per share, today.
2025/04/25
-
Press Releases
Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally
The global 2025 Curiosity Cube tour was launched today.
2025/04/24


Share Price
Check Share PriceShare Price

